跳至主要内容
临床试验/NCT00486746
NCT00486746Unknown不适用

Lifestyle Intervention Treatment for Patients With Mild Obstructive Sleep Apnea

Kuopio University Hospital2 个研究点 分布在 1 个国家目标入组 81 人开始时间: 2004年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
81
试验地点
2
主要终点
To evaluate, if weight reduction and lifestyle intervention improve the symptoms of mild obstructive sleep apnoea

研究概览

简要总结

The main objective of the study is to determine whether a supervised lifestyle intervention including individualized dietary counseling could be a curative treatment for patients with mild OSA.

详细描述

Obstructive sleep apnea (OSA) is one of the most common sleep disturbances, and it has been estimated that one out of five adults has at least some degree of sleep related breathing disturbances. Obstructive sleep apnea affects mostly the middle-aged work force, and causes a negative impact on public health by increasing both morbidity and mortality. Obesity is related to many diseases including diabetes, cardiovascular diseases, and metabolic syndrome,and obesity is also considered as the most important risk factor for OSA.Considering the prevalence of mild OSA, and the beneficial effects of even a slight weight loss on both the severity of OSA and the likelihood of developing OSA, lifestyle intervention including weight reduction represents a viable option for the treatment of patients with mild OSA.However, although included in the clinical guidelines, there is a definite lack of well executed studies on the effect of weight reduction upon OSA. Accordingly, we are conducting a randomized study on the effects of lifestyle intervention in the most prevalent subgroup of OSA patients, overweight patients with mild OSA. The study is an on-going prospective, randomized, parallel group trial. The main objective of the study is to determine whether a supervised lifestyle intervention including individualized dietary counseling could be a curative treatment for patients with mild OSA.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-65 years
  • Apnea-hypopnea index 5-15
  • BMI 28-40

排除标准

  • 未提供

结局指标

主要结局

To evaluate, if weight reduction and lifestyle intervention improve the symptoms of mild obstructive sleep apnoea

时间窗: 3 months

To evaluate, if these favourable changes remain in follow-up.

时间窗: 1, 2 and 5 years

次要结局

  • To evaluate, whether the treatment of mild OSA prevents the development of diseases in general associated with sleep apnoea(5 years)
  • To evaluate, whether the mild OSA has detrimental effects on cardiovascular functions and glucose-, insulin- and lipid metabolisms, regulation of autonomous nervous system, endothelial function, baroreflex sensitivity(baseline, 3 months, 1, 2 and 5 years)
  • To evaluate, if improvement of mild OSA has beneficial influence on quality of life, cardiovascular functions and glucose-, insulin- and lipid metabolisms, regulation of autonomous nervous system, endothelial function, and anatomy of the pharynx(1,2,5 years)

研究者

发起方
Kuopio University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Juha Seppa

PhD

Kuopio University Hospital

研究点 (2)

Loading locations...

相似试验